Response to comment on "Drug screening for ALS using patient-specific induced pluripotent stem cells"
- PMID: 23740898
- DOI: 10.1126/scitranslmed.3005697
Response to comment on "Drug screening for ALS using patient-specific induced pluripotent stem cells"
Abstract
Our work and the study of Bilican et al. highlight the need for complementary assays to detect subtle phenotypic differences between control and mutant induced pluripotent stem cell lines.
Comment on
-
Drug screening for ALS using patient-specific induced pluripotent stem cells.Sci Transl Med. 2012 Aug 1;4(145):145ra104. doi: 10.1126/scitranslmed.3004052. Sci Transl Med. 2012. PMID: 22855461
-
Comment on "Drug screening for ALS using patient-specific induced pluripotent stem cells".Sci Transl Med. 2013 Jun 5;5(188):188le2. doi: 10.1126/scitranslmed.3005065. Sci Transl Med. 2013. PMID: 23740897 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
